Sexually Transmitted Disease (STD) Diagnostics Market Growth, Demand and Challenges of the Key Industry Players 2024-2032

1
Global Sexually Transmitted Disease (STD)
Diagnostics Market Research and Forecast Report
2024-2032

• Format PDFEXCEL

2023 IMARC All Rights Reserved
2
About IMARC Group

• International Market Analysis Research and
  Consulting Group is a leading adviser on
  management strategy and market research
  worldwide. We partner with clients in all regions
  and industry verticals to identify their
  highest-value opportunities, address their most
  critical challenges, and transform their
  businesses.
• IMARCs information products include major
  market, scientific, economic and technological
  developments for business leaders in
  pharmaceutical, industrial, and high technology
  organizations. Market forecasts and industry
  analysis for biotechnology, advanced materials,
  chemicals, food and beverage, travel and tourism,
  nanotechnology and novel processing methods are
  at the top of the companys expertise.
• IMARCs tailored approach combines unfathomable
  insight into the dynamics of companies and
  markets with close cooperation at all levels of
  the client organization. This ensures that our
  clients achieve unmatchable competitive
  advantage, build more proficient organizations,
  and secure lasting results.

3
Report Highlight and Description

• According to the latest report by IMARC Group,
  titled "Sexually Transmitted Disease (STD)
  Diagnostics Market Global Industry Trends,
  Share, Size, Growth, Opportunity and Forecast
  2024-2032," the global sexually transmitted
  disease (STD) diagnostics market size reached US
  104.1 Billion in 2023.
• Sexually transmitted disease (STD) diagnostics
  refers to scientific tools and techniques used to
  identify, detect, and confirm the presence of
  STDs in an individual. It includes polymerase
  chain reaction (PCR) tests, nucleic acid
  amplification tests (NAATs), enzyme-linked
  immunosorbent assays (ELISAs), point-of-care
  (PoC) devices, and self-testing kits. STD
  diagnostics utilize blood, urine, genital swab,
  and fluid samples to detect the presence of
  pathogens and markers related to STDs.
• It is widely used to diagnose chlamydia,
  syphilis, gonorrhea, herpes, hepatitis B and C,
  human immunodeficiency virus (HIV), and human
  papillomavirus (HPV). STD diagnostics are highly
  efficient and accurate techniques that aid in the
  early detection of infections, enable timely
  intervention, prevent future complications, and
  increase patient outcomes.
• Request for a PDF sample of this report
  https//www.imarcgroup.com/sexually-transmitted-di
  sease-diagnostics-market/requestsample

4
Report Description

• Global Sexually Transmitted Disease (STD)
  Diagnostics Market Trends
• The rising prevalence of STDs due to unprotected
  sexual intercourse and drug abuse is one of the
  key factors propelling the market growth. STD
  diagnostics are widely used to determine the
  severity of infections, prevent further
  transmission, and identify potential treatment
  options to improve patient outcomes. Furthermore,
  the growing awareness among the masses regarding
  early disease detection to avoid various future
  complications, such as cancer, congenital
  disabilities, and infertility, is acting as
  another growth-inducing factor. Additionally, the
  recent development of multiplex assays, which
  allows simultaneous detection of multiple STD
  pathogens in a single test, thus, reducing costs,
  saving time, and improving diagnostic accuracy,
  is positively influencing the market growth.
• Besides this, the introduction of self-testing
  kits that allow individuals to conveniently test
  the presence of STDs in their homes without
  visiting healthcare facilities, which aids in
  improving accessibility, enhancing patient
  comfort, and maintaining privacy, is providing an
  impetus to the market growth. Apart from this,
  the implementation of supportive government
  policies to educate the masses about STDs,
  promote early detection, and provide access to
  high-quality treatment and testing facilities is
  contributing to the market growth. Other factors,
  including rising healthcare expenditure,
  increasing investment in the development of
  advanced diagnostic tools, and growing emphasis
  on sexual health among the masses, are
  anticipated to drive the market growth.
• Looking forward, the market is expected to reach
  US 159.5 Billion by 2032, exhibiting a CAGR of
  4.71 during 2024-2032.
• View Report TOC, Figures and Tables
  https//www.imarcgroup.com/sexually-transmitted-di
  sease-diagnostics-market

5
Report Segmentation

• Type Insights
• Chlamydia Testing
• Syphilis Testing
• Gonorrhea Testing
• Herpes Simplex Virus Testing
• Human Papilloma Virus Testing
• Human Immunodeficiency Virus Testing
• Chancroid Testing
• Others
• Device Type Insights
• Laboratory Devices
• Thermal Cycler PCR
• Lateral Flow Readers
• Flow Cytometers
• Absorbance Microplate Reader Enzyme Linked
  Immunosorbent Assay (ELISA)

6
Report Segmentation

• Others
• Point of Care (PoC) Devices
• Phone Chips (Microfluidics ICT)
• Portable/Bench Top/Rapid Diagnostic Kits
• End User Insights
• Laboratory Testing
• Point of Care (PoC) Testing
• Regional Insights
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

7
Competitive Landscape with Key Players

• Abbott Laboratories
• Becton Dickinson and Company
• BioMerieux SA
• Bio-Rad Laboratories Inc.
• Cepheid (Danaher Corporation)
• F. Hoffmann-La Roche AG
• Hologic Inc., Qiagen N.V.
• Quidel Corporation
• Siemens Healthineers AG (Siemens AG)

8
Key Questions Answered in the Report
9
Key Questions Answered in the Report
10
Table of Contents

• 1    Preface2    Scope and Methodology    2.1  
   Objectives of the Study    2.2  
   Stakeholders    2.3    Data Sources       
  2.3.1    Primary Sources        2.3.2  
   Secondary Sources    2.4    Market Estimation 
        2.4.1    Bottom-Up Approach        2.4.2  
   Top-Down Approach    2.5    Forecasting
  Methodology3    Executive Summary4  
   Introduction    4.1    Overview    4.2    Key
  Industry Trends5    Global Sexually Transmitted
  Disease (STD) Diagnostics Market    5.1  
   Market Overview    5.2    Market Performance 
    5.3    Impact of COVID-19  5.4    Market
  Forecast
• 6     Market Breakup by Type    6.1    Chlamydia
  Testing        6.1.1 Market Trends        6.1.2
  Market Forecast    6.2    Syphilis Testing     
    6.2.1 Market Trends        6.2.2 Market
  Forecast    6.3    Gonorrhea Testing       
  6.3.1 Market Trends        6.3.2 Market
  Forecast       

11
Table of Contents

•     6.4    Herpes Simplex Virus Testing       
  6.4.1 Market Trends        6.4.2 Market
  Forecast    6.5    Human Papilloma Virus
  Testing        6.5.1 Market Trends        6.5.2
  Market Forecast    6.6    Human Immunodeficiency
  Virus Testing        6.6.1 Market Trends       
  6.6.2 Market Forecast    6.7    Chancroid
  Testing        6.7.1 Market Trends        6.7.2
  Market Forecast    6.8    Others        6.8.1
  Market Trends        6.8.2 Market Forecast7  
   Market Breakup by Device Type    7.1  
   Laboratory Devices        7.1.1 Market Trends 
        7.1.2 Key Segments           7.1.2.1
  Thermal Cyclers - PCR           7.1.2.2 Lateral
  Flow Readers
•            7.1.2.3 Flow Cytometers         
   7.1.2.4 Absorbance Microplate Reader - Enzyme
  Linked Immunosorbent Assay (ELISA)         
   7.1.2.5 Others        7.1.3 Market Forecast   
  7.2    Point of Care (PoC) Devices        7.2.1
  Market Trends
• For more information, visit https//www.imarcgrou
  p.com/sexually-transmitted-disease-diagnostics-mar
  ket/toc

12
Disclaimer

• 2023 IMARC All Rights Reserved
• This Publication and all its contents unless
  otherwise mentioned are copyrighted in the name
  of International Market Analysis Research and
  Consulting (IMARC). No part of this publication
  may be reproduced, repackaged, redistributed or
  resold in whole or in any part. The publication
  may also not be used in any form or by and means
  graphic electronic or mechanical, including
  photocopying, recording, taping or by information
  storage or retrieval, or by any other form,
  without the express consent of International
  Market Analysis Research and Consulting (IMARC).
• Disclaimer All contents and data of this
  publication, including forecasts, data analysis
  and opinion have been based on information and
  sources believed to be accurate and reliable at
  the time of publishing. International Market
  Analysis Research and Consulting makes no
  representation of warranty of any kind as to the
  accuracy or completeness of any Information
  provided. IMARC accepts no liability whatsoever
  for any loss or damage resulting from opinion,
  errors or inaccuracies if any found this
  publication.
• IMARC, IMARC Group and Global Therapy Insight
  Series are registered trademarks of International
  Market Analysis Research and Consulting. All
  other trademarks used in this publication are
  registered trademarks of their respective
  companies.

13
Contact Us
Visit us at
https//www.imarcgroup.com
TELEPHONE [phone] E-MAIL
sales_at_imarcgroup.com